These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20722613)

  • 1. Bisphosphonates and bone diseases: past, present and future.
    Heymann D
    Curr Pharm Des; 2010; 16(27):2948-9. PubMed ID: 20722613
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological diversity among drugs that inhibit bone resorption.
    Russell RG
    Curr Opin Pharmacol; 2015 Jun; 22():115-30. PubMed ID: 26048735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates: effects on osteoblast.
    Maruotti N; Corrado A; Neve A; Cantatore FP
    Eur J Clin Pharmacol; 2012 Jul; 68(7):1013-8. PubMed ID: 22318756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonate therapy in the treatment of multiple myeloma.
    Lawson MA; Ashcroft J; Croucher PI
    Curr Pharm Des; 2010; 16(27):3028-36. PubMed ID: 20722619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant bisphosphonates in patients with breast cancer: does the potency matter?
    Amoroso V; Petrelli F; Pedersini R; Simoncini EL; Clézardin P; Barni S; Berruti A
    Future Oncol; 2015; 11(21):2853-6. PubMed ID: 26403833
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of bisphosphonates for treating pathological states in orthopedics].
    Białecki P; Bohatyrewicz A; Machoy-Mokrzyńska A; Białecka M
    Chir Narzadow Ruchu Ortop Pol; 2008; 73(4):266-73. PubMed ID: 18847019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of bisphosphonates on bone pain and quality of life in breast cancer patients with metastatic bone disease: a review.
    Diel IJ
    Support Care Cancer; 2007 Nov; 15(11):1243. PubMed ID: 17393190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone targeting agents: bisphosphonates].
    Debiais F
    Bull Cancer; 2013 Nov; 100(11):1199-206. PubMed ID: 24158668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages.
    Roelofs AJ; Thompson K; Ebetino FH; Rogers MJ; Coxon FP
    Curr Pharm Des; 2010; 16(27):2950-60. PubMed ID: 20722616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapeutic targets in myeloma bone disease.
    Webb SL; Edwards CM
    Br J Pharmacol; 2014 Aug; 171(16):3765-76. PubMed ID: 24750110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates, Old Friends of Bones and New Trends in Clinics.
    Barbosa JS; Almeida Paz FA; Braga SS
    J Med Chem; 2021 Feb; 64(3):1260-1282. PubMed ID: 33522236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates and metabolic bone disease in the ICU.
    Hollander JM; Mechanick JI
    Curr Opin Clin Nutr Metab Care; 2009 Mar; 12(2):190-5. PubMed ID: 19209471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological profile and clinical efficacy of minodronic acid hydrate as a new therapeutic agent for osteoporosis].
    Tanaka M; Mori H; Shimizu K; Toshiyuki ; Matsuoka ; Yamamotoya H; Minamide T; Mori M; Nozaki K; Usui T; Shimokawa K; Suzuki H; Aoyama K; Kimoto A; Sasamata M; Miyata K
    Nihon Yakurigaku Zasshi; 2009 Sep; 134(3):149-57. PubMed ID: 19749488
    [No Abstract]   [Full Text] [Related]  

  • 14. Bisphosphonates in orthopaedic surgery.
    Morris CD; Einhorn TA
    J Bone Joint Surg Am; 2005 Jul; 87(7):1609-18. PubMed ID: 15995133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Science-in-brief: Bisphosphonate use in the racehorse: Safe or unsafe?
    McLellan J
    Equine Vet J; 2017 Jul; 49(4):404-407. PubMed ID: 28603949
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current topics in drug therapy aiming at bone resorption].
    Yasui T; Tanaka S
    Clin Calcium; 2006 Sep; 16(9):1475-79. PubMed ID: 16951471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biphosphonate in the treatment of avascular necrosis of the femoral head].
    Shabtai L; Drexler M; Blummberg N
    Harefuah; 2012 Apr; 151(4):242-5, 252. PubMed ID: 22616155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denosumab for the treatment of bone disease in solid tumors and multiple myeloma.
    Yee AJ; Raje NS
    Future Oncol; 2018 Feb; 14(3):195-203. PubMed ID: 29052442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal use of bisphosphonates in patients with multiple myeloma.
    Terpos E; Roodman GD; Dimopoulos MA
    Blood; 2013 Apr; 121(17):3325-8. PubMed ID: 23407550
    [No Abstract]   [Full Text] [Related]  

  • 20. Lessons from rare diseases of cartilage and bone.
    Gallagher JA; Ranganath LR; Boyde A
    Curr Opin Pharmacol; 2015 Jun; 22():107-14. PubMed ID: 25978274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.